AUS
NZ
UK
CA
USA
IND
Cannabis
Cannabis Stocks Momentum Builds Across ASX 200
May 28, 2026 11:57 AM AEST| By SamCannabis Stocks on the ASX continue attracting attention as consolidation activity, benchmark participation, healthcare developments, and operational restructuring shape the evolving sector landscape.
Cannabis Stocks and ASX 300 Focus on Pharmacy Channels
May 28, 2026 11:57 AM AEST| By SamCannabis Stocks on the ASX remain linked with pharmacy participation, export frameworks, and healthcare distribution systems as sector attention continues across emerging medicinal cannabis operations and European commercial activity.
ASX Cannabis Stocks Active Across ASX 300 Discussions
May 28, 2026 11:50 AM AEST| By SamASX cannabis stocks remain active within Australia’s healthcare market as medicinal cannabis prescription activity and regulatory developments continue shaping sector discussions.
Noxopharm Gains Spotlight as Cancer Research Advances
May 27, 2026 07:38 PM AEST| By SamNoxopharm’s latest Sofra platform findings have renewed attention on cancer immunotherapy innovation as the biotech sector continues exploring advanced immune activation strategies for oncology treatment development.
ASX Cannabis Stock Risks: Key Traps to Watch
May 27, 2026 05:01 PM AEST| By SamASX cannabis stocks carry risks from volatility, regulation, funding needs, commercial adoption challenges, and execution pressure across Australia’s developing medicinal cannabis sector.
What’s Fueling Fresh Buzz Around ASX Cannabis Stocks?
May 27, 2026 04:27 PM AEST| By SamASX cannabis stocks continue evolving within Australia’s regulated medicinal cannabis market, with commercial adoption, operational execution, funding pressure, and healthcare-focused research shaping the sector’s outlook.
ASX Cannabis Stocks: What Smart Investors Are Watching
May 27, 2026 04:22 PM AEST| By SamASX cannabis stocks are increasingly assessed through commercial strength, operational execution, product economics and regulatory positioning as Australia’s medicinal cannabis industry continues maturing.
Cannabis Investment Risks: A Practical Guide for ASX Investors
May 26, 2026 03:03 PM AEST| By SamCannabis investing involves regulatory, commercial, and execution risks that Australian investors must manage thoughtfully through diversification, position sizing, and engagement with developments.
Evaluating Cannabis Companies: Beyond the Regulatory Headlines
May 26, 2026 02:57 PM AEST| By SamEvaluating cannabis businesses requires looking beyond regulatory headlines to examine commercial fundamentals, operational execution, and the specific economics of products in regulated markets.
Cannabis Stocks on the ASX: A Guide for Australian Investors
May 26, 2026 02:54 PM AEST| By SamHighlights,Cannabis stocks span medicinal, recreational, and adjacent businesses across different stages of regulatory and operational maturity.,Australian cannabis listings primarily focus on medicinal cannabis due to the local regulatory framework,...
Why ASX Healthcare Stocks Could Be Near a Turning Point
May 25, 2026 02:40 PM AEST| By SamEmerging ASX healthcare companies are regaining market attention as clinical progress, healthcare innovation, and commercial growth reshape sentiment across the sector.
Incannex Cannabis Gains Attention Across ASX 200 Healthcare Sector
May 11, 2026 01:45 PM AEST| By SamIncannex Healthcare remained under market focus as cannabis research and biotechnology activity continued shaping discussions across the Australian healthcare sector.
ASX 200 Update: Cannabis Sector and Healthcare Activity
May 07, 2026 11:32 AM AEST| By SamCannabis sector activity reflects developments across healthcare, biotechnology, and regulatory systems linked to production, research, and distribution within ASX 200 markets.
SOL vs Netwealth: Which ASX Share Looks More Attractive Now?
May 07, 2026 10:21 AM AEST| By SamSOL and Netwealth highlight contrasting ASX investment styles as investors weigh diversification, dividend stability, and digital wealth platform growth opportunities.
ASX All Ords Cannabis Watch: Cann Group Share Move
May 01, 2026 03:26 PM AEST| By SamCann Group advances share quotation activity within the ASX All Ordinaries, reflecting capital structuring efforts and growing participation in the healthcare and medicinal cannabis sector.
Cannabis Shift Sparks ASX Interest: What US Policy Means
April 30, 2026 05:46 PM AEST| By SamUS cannabis policy shift boosts sentiment across global markets, with ASX-listed players gaining attention as regulatory changes support medical use while broader reforms remain uncertain.
What Puts ASX 200 Incannex Cannabis Stocks in Focus?
April 27, 2026 02:07 PM AEST| By SamASX cannabis stocks reflect global regulatory developments, highlighting sector activity and evolving trends within healthcare and biotechnology industries.
ASX Healthcare Watch: Little Green Pharma Shares in Focus After Scheme Update
April 22, 2026 06:37 PM AEST| By SamLittle Green Pharma releases a scheme update, signalling ongoing corporate restructuring while highlighting transparency and strategic developments within the evolving healthcare sector.
Bioxyne Earnings Growth Sparks Interest in Cannabis Sector
April 20, 2026 02:32 PM AEST| By SamBioxyne’s earnings growth and insider confidence highlight improving momentum, positioning it as a notable company within the evolving ASX cannabis stock sector.
_10_31_2023_03_26_22_556942.jpg)
ASX Cannabis Stock Slips Amid Ongoing FDA Approval Process
October 31, 2023 02:23 PM AEDT| By Team Kalkine MediaWhile the broader All Ordinaries Index (ASX: XAO) has shown a positive trajectory during Tuesday's lunch hour, the cannabis sector tells a different story. Two,ASX-listed cannabis stocks,, Little Green Pharma Ltd and Botanix Pharmaceuticals Ltd, are...
Advertise your brand on Kalkine Media